We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $694M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+12.32%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$132M
AUM Growth
+$1.91M
Cap. Flow
-$9.22M
Cap. Flow %
-7%
Top 10 Hldgs %
55.66%
Holding
72
New
15
Increased
7
Reduced
12
Closed
11

Top Buys

1
HCA icon
HCA Healthcare
HCA
+$5.11M
2
AVNS icon
Avanos Medical
AVNS
+$3.8M
3
RVTY icon
Revvity
RVTY
+$3.35M
4
ELGX
Endologix Inc
ELGX
+$2.9M
5
NVRO
NEVRO CORP.
NVRO
+$2.66M

Top Sells

1
BIIB icon
Biogen
BIIB
+$7.56M
2
GSK icon
GSK
GSK
+$6.33M
3
CAH icon
Cardinal Health
CAH
+$4.73M
4
PBYI icon
Puma Biotechnology
PBYI
+$4.48M
5
SNY icon
Sanofi
SNY
+$4.24M

Sector Composition

1 Healthcare 81.21%
2 Financials 5.99%
3 Industrials 3.57%
4 Technology 1.12%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRAY
26
DELISTED
ViewRay, Inc.
VRAY
$2.03M 1.54%
+313,947
New +$2.1M
GYRE icon
27
Gyre Therapeutics
GYRE
$731M
$1.64M 1.25%
+47,090
New +$1.69M
VCRA
28
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.48M 1.12%
56,106
+6,235
+13% +$160K
ZYNE
29
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1.19M 0.91%
+70,300
New +$1.4M
CLVS
30
DELISTED
Clovis Oncology, Inc.
CLVS
$1.17M 0.89%
+12,500
New +$765K
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.17M 0.89%
+69,352
New +$951K
STDY
32
DELISTED
SteadyMed Ltd
STDY
$1.06M 0.8%
+168,000
New +$1.14M
AVDL
33
DELISTED
Avadel Pharmaceuticals
AVDL
$1.01M 0.76%
91,413
– –
AXSM icon
34
Axsome Therapeutics
AXSM
$12.1B
$880K 0.67%
160,000
-50,000
-24% -$209K
FOMX
35
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$646K 0.49%
+139,200
New +$621K
DMK
36
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$637K 0.48%
1,750
-10,862
-86% -$3.25M
SYRE icon
37
Spyre Therapeutics
SYRE
$8.68B
$499K 0.38%
5,183
-1,613
-24% -$223K
PFNX
38
DELISTED
Pfenex Inc.
PFNX
$344K 0.26%
85,867
– –
OASM
39
DELISTED
Oasmia Pharmaceutical AB
OASM
$214K 0.16%
203,170
+5,700
+3% +$10K
VIRX
40
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$91K 0.07%
963
-7,949
-89% -$913K
ABBV icon
41
AbbVie
ABBV
$437B
– –
0
– –
ACAD icon
42
Acadia Pharmaceuticals
ACAD
$4.45B
– –
0
– –
AGIO icon
43
Agios Pharmaceuticals
AGIO
$2.36B
– –
0
– –
ALNY icon
44
Alnylam Pharmaceuticals
ALNY
$37.5B
– –
0
– –
BIIB icon
45
Biogen
BIIB
$28.9B
– –
-27,650
Closed -$7.56M
BSX icon
46
Boston Scientific
BSX
$64.4B
– –
-90,000
Closed -$2.24M
CAH icon
47
Cardinal Health
CAH
$53.6B
– –
-57,950
Closed -$4.73M
CHRS icon
48
Coherus Oncology
CHRS
$222M
– –
-63,800
Closed -$1.35M
INSM icon
49
Insmed
INSM
$23.6B
– –
0
– –
IQV icon
50
IQVIA
IQV
$35B
– –
0
– –
1
2
3

Similar funds

IIC
Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
CGIC
Continental General Insurance Company Austin, Texas $693M AUM 90.58% 1-Year Est. Return
HA
Harbor Advisors West Palm Beach, Florida $692M AUM 33.65% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
M
MATAURO New York $692M AUM 26.24% 1-Year Est. Return
HG
Harbor Group Bedford, New Hampshire $692M AUM 13% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return